vs
Alignment Healthcare, Inc.（ALHC）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.0B、Alignment Healthcare, Inc.の約1.5倍）。Encompass Health Corpの純利益率が高く（9.5% vs -1.1%、差は10.5%）。Alignment Healthcare, Inc.の前年同期比売上増加率が高い（44.4% vs 9.9%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-55.4M）。過去8四半期でAlignment Healthcare, Inc.の売上複合成長率が高い（26.9% vs 8.3%）
Alignment Healthcare, Inc.は米国に本拠を置く医療企業で、高齢者向けメディケア・アドバンテージプランを提供しています。価値に基づく医療モデルを導入し、地域の医療機関と提携してきめ細かい医療サービスや処方薬保障、追加給付を提供し、米国複数州で事業を展開しています。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ALHC vs EHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.0B | $1.5B |
| 純利益 | $-11.0M | $146.1M |
| 粗利率 | — | — |
| 営業利益率 | -1.0% | 16.7% |
| 純利益率 | -1.1% | 9.5% |
| 売上前年比 | 44.4% | 9.9% |
| 純利益前年比 | 64.6% | 20.8% |
| EPS（希薄化後） | $-0.04 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $993.7M | $1.5B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $926.9M | $1.5B | ||
| Q4 24 | $701.2M | $1.4B | ||
| Q3 24 | $692.4M | $1.4B | ||
| Q2 24 | $681.3M | $1.3B | ||
| Q1 24 | $628.6M | $1.3B |
| Q4 25 | $-11.0M | $146.1M | ||
| Q3 25 | $3.7M | $126.5M | ||
| Q2 25 | $15.7M | $142.1M | ||
| Q1 25 | $-9.1M | $151.5M | ||
| Q4 24 | $-31.1M | $120.9M | ||
| Q3 24 | $-26.4M | $108.2M | ||
| Q2 24 | $-24.0M | $114.1M | ||
| Q1 24 | $-46.5M | $112.5M |
| Q4 25 | -1.0% | 16.7% | ||
| Q3 25 | 0.8% | 14.9% | ||
| Q2 25 | 2.2% | 16.2% | ||
| Q1 25 | -0.6% | 16.4% | ||
| Q4 24 | -3.2% | 14.3% | ||
| Q3 24 | -2.8% | 13.6% | ||
| Q2 24 | -2.7% | 14.3% | ||
| Q1 24 | -6.5% | 13.6% |
| Q4 25 | -1.1% | 9.5% | ||
| Q3 25 | 0.4% | 8.6% | ||
| Q2 25 | 1.5% | 9.7% | ||
| Q1 25 | -1.0% | 10.4% | ||
| Q4 24 | -4.4% | 8.6% | ||
| Q3 24 | -3.8% | 8.0% | ||
| Q2 24 | -3.5% | 8.8% | ||
| Q1 24 | -7.4% | 8.5% |
| Q4 25 | $-0.04 | $1.43 | ||
| Q3 25 | $0.02 | $1.24 | ||
| Q2 25 | $0.07 | $1.39 | ||
| Q1 25 | $-0.05 | $1.48 | ||
| Q4 24 | $-0.15 | $1.18 | ||
| Q3 24 | $-0.14 | $1.06 | ||
| Q2 24 | $-0.13 | $1.12 | ||
| Q1 24 | $-0.25 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $604.2M | $72.2M |
| 総負債低いほど良い | $323.2M | $2.4B |
| 株主資本純資産 | $179.3M | $2.4B |
| 総資産 | $1.1B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.80× | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $604.2M | $72.2M | ||
| Q3 25 | $644.1M | $48.7M | ||
| Q2 25 | $503.8M | $99.1M | ||
| Q1 25 | $479.5M | $95.8M | ||
| Q4 24 | $470.6M | $85.4M | ||
| Q3 24 | $381.0M | $147.8M | ||
| Q2 24 | $363.7M | $154.4M | ||
| Q1 24 | $301.7M | $134.4M |
| Q4 25 | $323.2M | $2.4B | ||
| Q3 25 | $322.7M | $2.4B | ||
| Q2 25 | $322.3M | $2.3B | ||
| Q1 25 | $321.9M | $2.3B | ||
| Q4 24 | $321.4M | $2.4B | ||
| Q3 24 | $212.0M | $2.3B | ||
| Q2 24 | $211.7M | $2.7B | ||
| Q1 24 | $162.0M | $2.7B |
| Q4 25 | $179.3M | $2.4B | ||
| Q3 25 | $161.9M | $2.4B | ||
| Q2 25 | $141.0M | $2.3B | ||
| Q1 25 | $108.1M | $2.2B | ||
| Q4 24 | $99.9M | $2.1B | ||
| Q3 24 | $114.5M | $2.0B | ||
| Q2 24 | $123.7M | $1.8B | ||
| Q1 24 | $130.9M | $1.7B |
| Q4 25 | $1.1B | $7.1B | ||
| Q3 25 | $1.1B | $6.9B | ||
| Q2 25 | $1.0B | $6.8B | ||
| Q1 25 | $895.6M | $6.6B | ||
| Q4 24 | $782.1M | $6.5B | ||
| Q3 24 | $692.3M | $6.5B | ||
| Q2 24 | $716.3M | $6.4B | ||
| Q1 24 | $633.2M | $6.2B |
| Q4 25 | 1.80× | 1.00× | ||
| Q3 25 | 1.99× | 1.01× | ||
| Q2 25 | 2.29× | 1.02× | ||
| Q1 25 | 2.98× | 1.08× | ||
| Q4 24 | 3.22× | 1.14× | ||
| Q3 24 | 1.85× | 1.20× | ||
| Q2 24 | 1.71× | 1.46× | ||
| Q1 24 | 1.24× | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-50.4M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $-55.4M | $116.7M |
| FCFマージンFCF / 売上 | -5.5% | 7.6% |
| 設備投資強度設備投資 / 売上 | 0.5% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | — | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $113.1M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-50.4M | $346.0M | ||
| Q3 25 | $144.6M | $270.8M | ||
| Q2 25 | $29.1M | $270.2M | ||
| Q1 25 | $16.6M | $288.6M | ||
| Q4 24 | $-8.7M | $278.8M | ||
| Q3 24 | $26.2M | $267.8M | ||
| Q2 24 | $23.5M | $217.4M | ||
| Q1 24 | $-6.2M | $238.8M |
| Q4 25 | $-55.4M | $116.7M | ||
| Q3 25 | $139.1M | $83.7M | ||
| Q2 25 | $21.1M | $113.3M | ||
| Q1 25 | $8.4M | $125.5M | ||
| Q4 24 | $-18.0M | $80.1M | ||
| Q3 24 | $16.9M | $120.3M | ||
| Q2 24 | $11.8M | $60.5M | ||
| Q1 24 | $-17.4M | $99.4M |
| Q4 25 | -5.5% | 7.6% | ||
| Q3 25 | 14.0% | 5.7% | ||
| Q2 25 | 2.1% | 7.8% | ||
| Q1 25 | 0.9% | 8.6% | ||
| Q4 24 | -2.6% | 5.7% | ||
| Q3 24 | 2.4% | 8.9% | ||
| Q2 24 | 1.7% | 4.6% | ||
| Q1 24 | -2.8% | 7.6% |
| Q4 25 | 0.5% | 14.8% | ||
| Q3 25 | 0.6% | 12.7% | ||
| Q2 25 | 0.8% | 10.8% | ||
| Q1 25 | 0.9% | 11.2% | ||
| Q4 24 | 1.3% | 14.1% | ||
| Q3 24 | 1.3% | 10.9% | ||
| Q2 24 | 1.7% | 12.1% | ||
| Q1 24 | 1.8% | 10.6% |
| Q4 25 | — | 2.37× | ||
| Q3 25 | 38.77× | 2.14× | ||
| Q2 25 | 1.86× | 1.90× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ALHC
セグメントデータなし
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
